眼圧亢進症治療の世界市場レポート 2025年

眼圧亢進症治療の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.1％で64億9,000万米ドルに成長します。予測期間の成長は、世界のヘルスケア支出の増加、治療方法の進歩、個別化医療の重視の高まり、遠隔医療サービスの統合、老人人口の増加などに起因しています。予測期間の世界の動向には、患者中心のアプローチ、規制状況の影響、世界市場の拡大、モニタリングデバイスの技術進歩、人工知能（AI）の統合などが含まれます。

緑内障の有病率の上昇が眼圧亢進症治療市場の拡大を牽引すると予測されます。緑内障は、視神経を損傷することで視力障害や失明に至る可能性のある慢性的な眼の病気であり、眼圧亢進症に直接関連し、永続的な視力障害を引き起こす眼疾患群の一因となっています。2022年10月にBrightFocus Foundation Highlightsが発表した予測では、世界全体で8,000万人が緑内障に罹患しており、2040年には1億1,100万人以上に急増すると予測されています。この緑内障患者数の増加が、眼圧亢進症治療市場の成長を裏付けています。

高齢化人口の増加は、眼圧亢進症治療市場の発展に拍車をかける。出生率の低下と平均寿命の延長により人口が高齢化すると、眼圧亢進症がより一般的になります。眼圧上昇のリスクは加齢とともに高まり、早期発見と管理のための定期的な眼科検診の重要性が強調されています。ARC Centre of Excellence in Population Ageing Researchの予測によると、オーストラリアの65歳以上の人口は2021年の推定431万人から2041年には666万人に増加し、54%増加する可能性があります。この人口動態の変化が、眼圧亢進症治療市場の拡大を裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界眼圧亢進症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の眼圧亢進症治療市場：成長率分析
• 世界の眼圧亢進症治療市場の実績：規模と成長, 2019-2024
• 世界の眼圧亢進症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界眼圧亢進症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の眼圧亢進症治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 眼圧亢進症
• 緑内障
• 世界の眼圧亢進症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他のルート
• 世界の眼圧亢進症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界の眼圧亢進症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他エンドユーザー
• 世界の眼圧亢進症治療市場、眼内圧亢進症の分類、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ遮断薬
• プロスタグランジン類似体
• 炭酸脱水酵素阻害剤
• アルファ作動薬
• Rhoキナーゼ阻害剤
• 世界の眼圧亢進症治療市場緑内障の種類別の分類、実績と予測, 2019-2024, 2024-2029F, 2034F
• 開放隅角緑内障の治療
• 閉塞隅角緑内障の治療
• 二次緑内障の治療
• 先天性緑内障の治療
• 併用療法

第7章 地域別・国別分析

• 世界の眼圧亢進症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の眼圧亢進症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 眼圧亢進症治療市場：競合情勢
• 眼圧亢進症治療市場：企業プロファイル
  • Angelini SpA Overview, Products and Services, Strategy and Financial Analysis
  • Laboratorios Sophia Overview, Products and Services, Strategy and Financial Analysis
  • Neurim Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Nicox SA Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AbbVie Inc.
• Alcon
• Ocular Therapeutix Inc.
• Sylentis S.A
• Taejoon Pharma Co. Ltd.
• Bausch Health Companies Inc.
• Merck & Co. Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Laboratorios Salvat SA
• Shionogi & Co. Ltd.
• Otsuka Holdings Co. Ltd.
• Mitsubishi Tanabe Pharma Corporation
• Astellas Pharma Inc.
• Eisai Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 眼圧亢進症治療市場2029：新たな機会を提供する国
• 眼圧亢進症治療市場2029：新たな機会を提供するセグメント
• 眼圧亢進症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ocular hypertension treatment encompasses strategies aimed at managing and lowering elevated intraocular pressure (IOP) in individuals diagnosed with this condition. This treatment is crucial for safeguarding the optic nerve, preserving visual function, and maintaining overall ocular health.

The primary categories of ocular hypertension treatment involve addressing intraocular pressure and managing glaucoma. Intraocular hypertension specifically denotes heightened pressure within the eye, particularly in the fluid-filled anterior chamber. These treatments are delivered through oral, parenteral, and various other administration routes, distributed across hospital pharmacies, retail outlets, online platforms, and similar channels. The key end-users of ocular hypertension treatment include hospitals, specialized clinics, and related establishments.

The ocular hypertension treatment market research report is one of a series of new reports from The Business Research Company that provides ocular hypertension treatment market statistics, including the ocular hypertension treatment industry's global market size, regional shares, competitors with an ocular hypertension treatment market share, detailed ocular hypertension treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the ocular hypertension treatment industry. This ocular hypertension treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ocular hypertension treatment market size has grown steadily in recent years. It will grow from$5.37 billion in 2024 to $5.53 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increased aging population, high incidence of glaucoma, advancements in diagnostic tools, awareness and screenings, lifestyle changes and urbanization

The ocular hypertension treatment market size is expected to see steady growth in the next few years. It will grow to $6.49 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising global healthcare expenditure, advancements in treatment modalities, increased emphasis on personalized medicine, integration of telehealth services, rising geriatric population. Major trends in the forecast period include patient-centric approaches, regulatory landscape impact, global market expansion, technological advancements in monitoring devices, integration of artificial intelligence (AI).

The escalating prevalence of glaucoma is anticipated to drive the expansion of the ocular hypertension treatment market. Glaucoma, a chronic eye ailment leading to potential vision impairment and blindness by damaging the optic nerve, has a direct link to ocular hypertension, contributing to a cluster of eye conditions causing lasting visual impairment. Projections from the BrightFocus Foundation Highlights in October 2022 indicated that globally, 80 million individuals were affected by glaucoma, with estimates predicting a surge to over 111 million by 2040. This projected rise in glaucoma instances substantiates the growth of the ocular hypertension treatment market.

The growth of the aging demographic is poised to fuel advancements in the ocular hypertension treatment market. As populations age due to declining birth rates and extended life expectancy, ocular hypertension becomes more prevalent. Heightened intraocular pressure risk elevates with age, underscoring the significance of regular eye screenings for early detection and management. Forecasts from the ARC Centre of Excellence in Population Ageing Research suggest Australia's 65-and-above population could grow to 6.66 million by 2041 from an estimated 4.31 million in 2021, marking a 54% increase. This demographic shift substantiates the expansion of the ocular hypertension treatment market.

Innovation stands as a prominent trend propelling the ocular hypertension treatment market. Companies within this sector are actively embracing novel technologies to fortify their market standing. For instance, in April 2022, Sandoz, a Switzerland-based generics and biosimilars manufacturer, introduced the Brimonidine tartrate/timolol maleate ophthalmic solution. This eye drop combination, available in generic forms of 0.2% or 0.5%, effectively reduces eye pressure in individuals with ocular hypertension. Fixed medication combinations offer patients simplicity, improved compliance, reduced exposure to preservatives, and potential cost savings.

Notable players in the ocular hypertension treatment market are forging strategic partnerships and collaborations to fortify their market presence. These alliances, formed to achieve specific business objectives, are gaining prominence. For instance, in July 2022, AbbVie Inc., a US-based pharmaceutical firm, announced a strategic collaboration with iSTAR Medical SA, a Belgian clinical-stage medical technology company, to advance and commercialize the MINIject device. This minimally invasive glaucoma surgical (MIGS) device, designed to reduce intraocular pressure in primary open-angle glaucoma patients, expands AbbVie's eye care portfolio. The collaboration aims to expedite the development and market availability of the MINIject device, offering a novel treatment avenue for glaucoma patients.

In November 2022, Alcon, a pharmaceutical and medical device company headquartered in the US, completed the acquisition of Aerie Pharmaceuticals Inc., a clinical-stage pharmaceutical firm based in the US, for an undisclosed amount. This strategic acquisition significantly enhances Alcon's portfolio of commercial offerings and bolsters its developmental pipeline within the ocular hypertension treatment market.

Major companies operating in the ocular hypertension treatment market include Angelini SpA, Laboratorios Sophia, Neurim Pharmaceuticals Ltd., Nicox SA, Novartis AG, AbbVie Inc., Alcon, Ocular Therapeutix Inc., Sylentis S.A, Taejoon Pharma Co. Ltd., Bausch Health Companies Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Laboratorios Salvat SA, Shionogi & Co. Ltd., Otsuka Holdings Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Eisai Co. Ltd., Daiichi Sankyo Company Limited, Celgene Corporation, Boehringer Ingelheim International GmbH, SK Bioscience Co., Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited

North America was the largest region in the ocular hypertension treatment market in 2024. The regions covered in the ocular hypertension treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ocular hypertension treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ocular hypertension treatment market includes revenues earned by entities by providing carbonic anhydrase inhibitors, prostaglandins, and beta-blockers that are used to treat ocular hypertension. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Hypertension Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular hypertension treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular hypertension treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ocular hypertension treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Intraocular Hypertension; Glaucoma
• 2) By Route of Administration: Oral; Parenteral; Other Routes
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel
• 4) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Intraocular Hypertension: Beta Blockers; Prostaglandin Analogs; Carbonic Anhydrase Inhibitors; Alpha Agonists; Rho Kinase Inhibitors
• 2) By Glaucoma: Open-Angle Glaucoma Treatments; Angle-Closure Glaucoma Treatments; Secondary Glaucoma Treatments; Congenital Glaucoma Treatments; Combination Therapies
• Companies Mentioned: Angelini SpA; Laboratorios Sophia; Neurim Pharmaceuticals Ltd.; Nicox SA; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Hypertension Treatment Market Characteristics

3. Ocular Hypertension Treatment Market Trends And Strategies

4. Ocular Hypertension Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Ocular Hypertension Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ocular Hypertension Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ocular Hypertension Treatment Market Growth Rate Analysis
• 5.4. Global Ocular Hypertension Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ocular Hypertension Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ocular Hypertension Treatment Total Addressable Market (TAM)

6. Ocular Hypertension Treatment Market Segmentation

• 6.1. Global Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intraocular Hypertension
• Glaucoma
• 6.2. Global Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes
• 6.3. Global Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channel
• 6.4. Global Ocular Hypertension Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Others End-Users
• 6.5. Global Ocular Hypertension Treatment Market, Sub-Segmentation Of Intraocular Hypertension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta Blockers
• Prostaglandin Analogs
• Carbonic Anhydrase Inhibitors
• Alpha Agonists
• Rho Kinase Inhibitors
• 6.6. Global Ocular Hypertension Treatment Market, Sub-Segmentation Of Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open-Angle Glaucoma Treatments
• Angle-Closure Glaucoma Treatments
• Secondary Glaucoma Treatments
• Congenital Glaucoma Treatments
• Combination Therapies

7. Ocular Hypertension Treatment Market Regional And Country Analysis

• 7.1. Global Ocular Hypertension Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ocular Hypertension Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ocular Hypertension Treatment Market

• 8.1. Asia-Pacific Ocular Hypertension Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ocular Hypertension Treatment Market

• 9.1. China Ocular Hypertension Treatment Market Overview
• 9.2. China Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ocular Hypertension Treatment Market

• 10.1. India Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ocular Hypertension Treatment Market

• 11.1. Japan Ocular Hypertension Treatment Market Overview
• 11.2. Japan Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ocular Hypertension Treatment Market

• 12.1. Australia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ocular Hypertension Treatment Market

• 13.1. Indonesia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ocular Hypertension Treatment Market

• 14.1. South Korea Ocular Hypertension Treatment Market Overview
• 14.2. South Korea Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ocular Hypertension Treatment Market

• 15.1. Western Europe Ocular Hypertension Treatment Market Overview
• 15.2. Western Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ocular Hypertension Treatment Market

• 16.1. UK Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ocular Hypertension Treatment Market

• 17.1. Germany Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ocular Hypertension Treatment Market

• 18.1. France Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ocular Hypertension Treatment Market

• 19.1. Italy Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ocular Hypertension Treatment Market

• 20.1. Spain Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ocular Hypertension Treatment Market

• 21.1. Eastern Europe Ocular Hypertension Treatment Market Overview
• 21.2. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ocular Hypertension Treatment Market

• 22.1. Russia Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ocular Hypertension Treatment Market

• 23.1. North America Ocular Hypertension Treatment Market Overview
• 23.2. North America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ocular Hypertension Treatment Market

• 24.1. USA Ocular Hypertension Treatment Market Overview
• 24.2. USA Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ocular Hypertension Treatment Market

• 25.1. Canada Ocular Hypertension Treatment Market Overview
• 25.2. Canada Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ocular Hypertension Treatment Market

• 26.1. South America Ocular Hypertension Treatment Market Overview
• 26.2. South America Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ocular Hypertension Treatment Market

• 27.1. Brazil Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ocular Hypertension Treatment Market

• 28.1. Middle East Ocular Hypertension Treatment Market Overview
• 28.2. Middle East Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ocular Hypertension Treatment Market

• 29.1. Africa Ocular Hypertension Treatment Market Overview
• 29.2. Africa Ocular Hypertension Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ocular Hypertension Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ocular Hypertension Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ocular Hypertension Treatment Market Competitive Landscape And Company Profiles

• 30.1. Ocular Hypertension Treatment Market Competitive Landscape
• 30.2. Ocular Hypertension Treatment Market Company Profiles
  • 30.2.1. Angelini SpA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratorios Sophia Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Neurim Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nicox SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Ocular Hypertension Treatment Market Other Major And Innovative Companies

• 31.1. AbbVie Inc.
• 31.2. Alcon
• 31.3. Ocular Therapeutix Inc.
• 31.4. Sylentis S.A
• 31.5. Taejoon Pharma Co. Ltd.
• 31.6. Bausch Health Companies Inc.
• 31.7. Merck & Co. Inc.
• 31.8. Pfizer Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Laboratorios Salvat SA
• 31.11. Shionogi & Co. Ltd.
• 31.12. Otsuka Holdings Co. Ltd.
• 31.13. Mitsubishi Tanabe Pharma Corporation
• 31.14. Astellas Pharma Inc.
• 31.15. Eisai Co. Ltd.

32. Global Ocular Hypertension Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ocular Hypertension Treatment Market

34. Recent Developments In The Ocular Hypertension Treatment Market

35. Ocular Hypertension Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Ocular Hypertension Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ocular Hypertension Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ocular Hypertension Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer